Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

The emerging role of human cytomegalovirus infection in human carcinogenesis: a review of current evidence and potential therapeutic implications.

Nauclér CS, Geisler J, Vetvik K.

Oncotarget. 2019 Jul 2;10(42):4333-4347. doi: 10.18632/oncotarget.27016. eCollection 2019 Jul 2. Review.

2.

Expression of Oncogenic Alleles Induces Multiple Blocks to Human Cytomegalovirus Infection.

Xu S, Schafer X, Munger J.

J Virol. 2016 Apr 14;90(9):4346-4356. doi: 10.1128/JVI.00179-16. Print 2016 May.

3.

Human cytomegalovirus modulates monocyte-mediated innate immune responses during short-term experimental latency in vitro.

Noriega VM, Haye KK, Kraus TA, Kowalsky SR, Ge Y, Moran TM, Tortorella D.

J Virol. 2014 Aug;88(16):9391-405. doi: 10.1128/JVI.00934-14. Epub 2014 Jun 11.

4.

Modulatory effects of human cytomegalovirus infection on malignant properties of cancer cells.

Cinatl J Jr, Cinatl J, Vogel JU, Rabenau H, Kornhuber B, Doerr HW.

Intervirology. 1996;39(4):259-69. Review.

PMID:
9078467
5.

The Human Cytomegalovirus, from Oncomodulation to Oncogenesis.

Herbein G.

Viruses. 2018 Aug 3;10(8). pii: E408. doi: 10.3390/v10080408. Review.

6.

Human cytomegalovirus latent infection alters the expression of cellular and viral microRNA.

Fu M, Gao Y, Zhou Q, Zhang Q, Peng Y, Tian K, Wang J, Zheng X.

Gene. 2014 Feb 25;536(2):272-8. doi: 10.1016/j.gene.2013.12.012. Epub 2013 Dec 18.

PMID:
24361963
7.

Human Cytomegalovirus Induces an Atypical Activation of Akt To Stimulate the Survival of Short-Lived Monocytes.

Cojohari O, Peppenelli MA, Chan GC.

J Virol. 2016 Jun 24;90(14):6443-6452. doi: 10.1128/JVI.00214-16. Print 2016 Jul 15.

8.

Human cytomegalovirus and mucoepidermoid carcinoma of salivary glands: cell-specific localization of active viral and oncogenic signaling proteins is confirmatory of a causal relationship.

Melnick M, Sedghizadeh PP, Allen CM, Jaskoll T.

Exp Mol Pathol. 2012 Feb;92(1):118-25. doi: 10.1016/j.yexmp.2011.10.011. Epub 2011 Nov 10.

PMID:
22101257
9.

Human Cytomegalovirus Promotes Survival of Infected Monocytes via a Distinct Temporal Regulation of Cellular Bcl-2 Family Proteins.

Collins-McMillen D, Kim JH, Nogalski MT, Stevenson EV, Chan GC, Caskey JR, Cieply SJ, Yurochko AD.

J Virol. 2015 Dec 16;90(5):2356-71. doi: 10.1128/JVI.01994-15.

10.

Bioactive Molecules Released From Cells Infected with the Human Cytomegalovirus.

Luganini A, Terlizzi ME, Gribaudo G.

Front Microbiol. 2016 May 13;7:715. doi: 10.3389/fmicb.2016.00715. eCollection 2016. Review.

11.

Antagonistic determinants controlling replicative and latent states of human cytomegalovirus infection.

Umashankar M, Rak M, Bughio F, Zagallo P, Caviness K, Goodrum FD.

J Virol. 2014 Jun;88(11):5987-6002. doi: 10.1128/JVI.03506-13. Epub 2014 Mar 12.

12.

Latency-Associated Expression of Human Cytomegalovirus US28 Attenuates Cell Signaling Pathways To Maintain Latent Infection.

Krishna BA, Poole EL, Jackson SE, Smit MJ, Wills MR, Sinclair JH.

MBio. 2017 Dec 5;8(6). pii: e01754-17. doi: 10.1128/mBio.01754-17.

13.

Human Cytomegalovirus Requires Epidermal Growth Factor Receptor Signaling To Enter and Initiate the Early Steps in the Establishment of Latency in CD34+ Human Progenitor Cells.

Kim JH, Collins-McMillen D, Buehler JC, Goodrum FD, Yurochko AD.

J Virol. 2017 Feb 14;91(5). pii: e01206-16. doi: 10.1128/JVI.01206-16. Print 2017 Mar 1.

14.

The Human Cytomegalovirus Strain DB Activates Oncogenic Pathways in Mammary Epithelial Cells.

Kumar A, Tripathy MK, Pasquereau S, Al Moussawi F, Abbas W, Coquard L, Khan KA, Russo L, Algros MP, Valmary-Degano S, Adotevi O, Morot-Bizot S, Herbein G.

EBioMedicine. 2018 Apr;30:167-183. doi: 10.1016/j.ebiom.2018.03.015. Epub 2018 Mar 28.

15.

Human Cytomegalovirus UL111A and US27 Gene Products Enhance the CXCL12/CXCR4 Signaling Axis via Distinct Mechanisms.

Tu CC, Arnolds KL, O'Connor CM, Spencer JV.

J Virol. 2018 Feb 12;92(5). pii: e01981-17. doi: 10.1128/JVI.01981-17. Print 2018 Mar 1.

16.

The oncogenic potential of human cytomegalovirus and breast cancer.

Herbein G, Kumar A.

Front Oncol. 2014 Aug 25;4:230. doi: 10.3389/fonc.2014.00230. eCollection 2014. Review.

17.

Human Cytomegalovirus UL135 Interacts with Host Adaptor Proteins To Regulate Epidermal Growth Factor Receptor and Reactivation from Latency.

Rak MA, Buehler J, Zeltzer S, Reitsma J, Molina B, Terhune S, Goodrum F.

J Virol. 2018 Sep 26;92(20). pii: e00919-18. doi: 10.1128/JVI.00919-18. Print 2018 Oct 15.

18.

Maintenance of large numbers of virus genomes in human cytomegalovirus-infected T98G glioblastoma cells.

Duan YL, Ye HQ, Zavala AG, Yang CQ, Miao LF, Fu BS, Seo KS, Davrinche C, Luo MH, Fortunato EA.

J Virol. 2014 Apr;88(7):3861-73. doi: 10.1128/JVI.01166-13. Epub 2014 Jan 22.

19.

Efficient Delivery of Human Cytomegalovirus T Cell Antigens by Attenuated Sendai Virus Vectors.

Kiener R, Fleischmann M, Wiegand MA, Lemmermann NAW, Schwegler C, Kaufmann C, Renzaho A, Thomas S, Felder E, Niller HH, Asbach B, Wagner R.

J Virol. 2018 Jul 17;92(15). pii: e00569-18. doi: 10.1128/JVI.00569-18. Print 2018 Aug 1.

Supplemental Content

Support Center